TP53 Restoration Sensitizes Pancreatic Cancer to Multiple Drugs
May 5, 2022
In Aging’s Volume 14, Issue 8, cover paper, researchers found that the restoration of wild-type TP53 decreased pancreatic cancer cell resistance to various drugs, including rapamycin. continue reading »